Lv4
450 积分 2024-11-21 加入
Alternative Complement Pathway, Iptacopan, and IgA Nephropathy
2天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
2天前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
2天前
已完结
Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice
2天前
已完结
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
5天前
已完结
Phase III FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis
19天前
已完结
Exploring the potential of Rho kinase inhibitors in ophthalmology: From mechanisms to clinical practice
1个月前
已完结
Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema
1个月前
已完结
Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis
1个月前
已完结
S100A4 a classical DAMP as a therapeutic target in fibrosis
1个月前
已完结
皖公网安备34019202002308
